 | | PATHWAY: mmei01100 | |
| Entry |
|
| Name |
Metabolic pathways - Mesorhizobium mediterraneum |
| Class |
|
| Pathway map |

|
| Module |
| mmei_M00007 | Pentose phosphate pathway, non-oxidative phase, fructose-6P => ribose-5P [PATH:mmei01100] |
| mmei_M00019 | Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine [PATH:mmei01100] |
| mmei_M00046 | Pyrimidine degradation, uracil => beta-alanine, thymine => 3-aminoisobutanoate [PATH:mmei01100] |
| mmei_M00061 | D-Glucuronate degradation, D-glucuronate => pyruvate + D-glyceraldehyde-3P [PATH:mmei01100] |
| mmei_M00552 | Galactonate degradation, De Ley-Doudoroff pathway, galactonate => glycerate-3P [PATH:mmei01100] |
| mmei_M00881 | Lipoic acid biosynthesis, plants and bacteria, octanoyl-ACP => dihydrolipoyl-E2/H [PATH:mmei01100] |
|
| Organism |
Mesorhizobium mediterraneum [GN: mmei]
|
Related pathway |
| mmei00040 | Pentose and glucuronate interconversions |
| mmei00130 | Ubiquinone and other terpenoid-quinone biosynthesis |
| mmei00250 | Alanine, aspartate and glutamate metabolism |
| mmei00260 | Glycine, serine and threonine metabolism |
| mmei00280 | Valine, leucine and isoleucine degradation |
| mmei00290 | Valine, leucine and isoleucine biosynthesis |
| mmei00361 | Chlorocyclohexane and chlorobenzene degradation |
| mmei00400 | Phenylalanine, tyrosine and tryptophan biosynthesis |
| mmei00440 | Phosphonate and phosphinate metabolism |
| mmei00520 | Amino sugar and nucleotide sugar metabolism |
| mmei00525 | Acarbose and validamycin biosynthesis |
| mmei00541 | Biosynthesis of various nucleotide sugars |
| mmei00625 | Chloroalkane and chloroalkene degradation |
| mmei00630 | Glyoxylate and dicarboxylate metabolism |
| mmei00660 | C5-Branched dibasic acid metabolism |
| mmei00760 | Nicotinate and nicotinamide metabolism |
| mmei00907 | Pinene, camphor and geraniol degradation |
| mmei00975 | Biosynthesis of various siderophores |
| mmei00999 | Biosynthesis of various plant secondary metabolites |
| mmei01040 | Biosynthesis of unsaturated fatty acids |
|
| KO pathway |
|
|
|